Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2016

01-03-2016 | Original Article

Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice

Authors: Germaine Korner, Tanja Scherer, Dea Adamsen, Alexander Rebuffat, Mark Crabtree, Anahita Rassi, Rossana Scavelli, Daigo Homma, Birgit Ledermann, Daniel Konrad, Hiroshi Ichinose, Christian Wolfrum, Marion Horsch, Birgit Rathkolb, Martin Klingenspor, Johannes Beckers, Eckhard Wolf, Valérie Gailus-Durner, Helmut Fuchs, Martin Hrabě de Angelis, Nenad Blau, Jan Rozman, Beat Thöny

Published in: Journal of Inherited Metabolic Disease | Issue 2/2016

Login to get access

Abstract

Tetrahydrobiopterin (BH4) is an essential cofactor for the aromatic amino acid hydroxylases, alkylglycerol monooxygenase, and nitric oxide synthases (NOS). Inborn errors of BH4 metabolism lead to severe insufficiency of brain monoamine neurotransmitters while augmentation of BH4 by supplementation or stimulation of its biosynthesis is thought to ameliorate endothelial NOS (eNOS) dysfunction, to protect from (cardio-) vascular disease and/or prevent obesity and development of the metabolic syndrome. We have previously reported that homozygous knock-out mice for the 6-pyruvolytetrahydropterin synthase (PTPS; Pts-ko/ko) mice with no BH4 biosynthesis die after birth. Here we generated a Pts-knock-in (Pts-ki) allele expressing the murine PTPS-p.Arg15Cys with low residual activity (15 % of wild-type in vitro) and investigated homozygous (Pts-ki/ki) and compound heterozygous (Pts-ki/ko) mutants. All mice showed normal viability and depending on the severity of the Pts alleles exhibited up to 90 % reduction of PTPS activity concomitant with neopterin elevation and mild reduction of total biopterin while blood L-phenylalanine and brain monoamine neurotransmitters were unaffected. Yet, adult mutant mice with compromised PTPS activity (i.e., Pts-ki/ko, Pts-ki/ki or Pts-ko/wt) had increased body weight and elevated intra-abdominal fat. Comprehensive phenotyping of Pts-ki/ki mice revealed alterations in energy metabolism with proportionally higher fat content but lower lean mass, and increased blood glucose and cholesterol. Transcriptome analysis indicated changes in glucose and lipid metabolism. Furthermore, differentially expressed genes associated with obesity, weight loss, hepatic steatosis, and insulin sensitivity were consistent with the observed phenotypic alterations. We conclude that reduced PTPS activity concomitant with mildly compromised BH4-biosynthesis leads to abnormal body fat distribution and abdominal obesity at least in mice. This study associates a novel single gene mutation with monogenic forms of obesity.
Appendix
Available only for authorised users
Literature
go back to reference Alp NJ, Mussa S, Khoo J et al (2003) Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112:725–735PubMedCentralCrossRefPubMed Alp NJ, Mussa S, Khoo J et al (2003) Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112:725–735PubMedCentralCrossRefPubMed
go back to reference Babaev VR, Runner RP, Fan D et al (2011) Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-gamma-regulated genes. Arterioscler Thromb Vasc Biol 31:1283–1290PubMedCentralCrossRefPubMed Babaev VR, Runner RP, Fan D et al (2011) Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-gamma-regulated genes. Arterioscler Thromb Vasc Biol 31:1283–1290PubMedCentralCrossRefPubMed
go back to reference Burke SJ, Goff MR, Updegraff BL et al (2012) Regulation of the CCL2 gene in pancreatic beta-cells by IL-1beta and glucocorticoids: role of MKP-1. PLoS One 7:e46986PubMedCentralCrossRefPubMed Burke SJ, Goff MR, Updegraff BL et al (2012) Regulation of the CCL2 gene in pancreatic beta-cells by IL-1beta and glucocorticoids: role of MKP-1. PLoS One 7:e46986PubMedCentralCrossRefPubMed
go back to reference Daugherity EK, Balmus G, Al Saei A et al (2012) The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. Cell Cycle 11:1918–1928PubMedCentralCrossRefPubMed Daugherity EK, Balmus G, Al Saei A et al (2012) The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. Cell Cycle 11:1918–1928PubMedCentralCrossRefPubMed
go back to reference De Rosa S, Cirillo P, Pacileo M et al (2011) Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharmacol 9:188–199CrossRefPubMed De Rosa S, Cirillo P, Pacileo M et al (2011) Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharmacol 9:188–199CrossRefPubMed
go back to reference Duplain H, Burcelin R, Sartori C et al (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342–345CrossRefPubMed Duplain H, Burcelin R, Sartori C et al (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342–345CrossRefPubMed
go back to reference Elzaouk L, Leimbacher W, Turri M et al (2003) Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts−/− mice rescued by feeding neurotransmitter precursors and H4-biopterin. J Biol Chem 278:28303–28311CrossRefPubMed Elzaouk L, Leimbacher W, Turri M et al (2003) Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts−/− mice rescued by feeding neurotransmitter precursors and H4-biopterin. J Biol Chem 278:28303–28311CrossRefPubMed
go back to reference Embury JE, Charron CE, Martynyuk A et al (2007) PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice. Brain Res 1127:136–150PubMedCentralCrossRefPubMed Embury JE, Charron CE, Martynyuk A et al (2007) PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice. Brain Res 1127:136–150PubMedCentralCrossRefPubMed
go back to reference Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708–1714CrossRefPubMed Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708–1714CrossRefPubMed
go back to reference Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 116:39–48CrossRef Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 116:39–48CrossRef
go back to reference Gailus-Durner V, Fuchs H, Becker L et al (2005) Introducing the German mouse clinic: open access platform for standardized phenotyping. Nat Methods 2:403–404CrossRefPubMed Gailus-Durner V, Fuchs H, Becker L et al (2005) Introducing the German mouse clinic: open access platform for standardized phenotyping. Nat Methods 2:403–404CrossRefPubMed
go back to reference Gailus-Durner V, Fuchs H, Adler T et al (2009) Systemic first-line phenotyping. Methods Mol Biol 530:463–509CrossRef Gailus-Durner V, Fuchs H, Adler T et al (2009) Systemic first-line phenotyping. Methods Mol Biol 530:463–509CrossRef
go back to reference Ghosh PM, Shu ZJ, Zhu B et al (2012) Role of beta-adrenergic receptors in regulation of hepatic fat accumulation during aging. J Endocrinol 213:251–261PubMedCentralCrossRefPubMed Ghosh PM, Shu ZJ, Zhu B et al (2012) Role of beta-adrenergic receptors in regulation of hepatic fat accumulation during aging. J Endocrinol 213:251–261PubMedCentralCrossRefPubMed
go back to reference Guenard F, Bouchard L, Tchernof A et al (2013) DUSP1 gene polymorphisms are associated with obesity-related metabolic complications among severely obese patients and impact on gene methylation and expression. Int J Genomics 2013:609748PubMedCentralCrossRefPubMed Guenard F, Bouchard L, Tchernof A et al (2013) DUSP1 gene polymorphisms are associated with obesity-related metabolic complications among severely obese patients and impact on gene methylation and expression. Int J Genomics 2013:609748PubMedCentralCrossRefPubMed
go back to reference Ihlemann N, Rask-Madsen C, Perner A et al (2003) Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 285:H875–H882CrossRef Ihlemann N, Rask-Madsen C, Perner A et al (2003) Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 285:H875–H882CrossRef
go back to reference Joseph B, Dyer CA (2003) Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J Neurochem 86:615–626CrossRefPubMed Joseph B, Dyer CA (2003) Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J Neurochem 86:615–626CrossRefPubMed
go back to reference Leeming RJ, Blair JA, Melikian V, O’Gorman DJ (1976) Biopterin derivatives in human body fluids and tissues. J Clin Pathol 29:444–451PubMedCentralCrossRef Leeming RJ, Blair JA, Melikian V, O’Gorman DJ (1976) Biopterin derivatives in human body fluids and tissues. J Clin Pathol 29:444–451PubMedCentralCrossRef
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408 Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
go back to reference Matsubara Y, Gaull GE (1985) Biopterin and neopterin in various milks and infant formulas. Am J Clin Nutr 41:110–112PubMed Matsubara Y, Gaull GE (1985) Biopterin and neopterin in various milks and infant formulas. Am J Clin Nutr 41:110–112PubMed
go back to reference McNeill E, Channon KM (2012) The role of tetrahydrobiopterin in inflammation and cardiovascular disease. Thromb Haemost 108:832–839CrossRefPubMed McNeill E, Channon KM (2012) The role of tetrahydrobiopterin in inflammation and cardiovascular disease. Thromb Haemost 108:832–839CrossRefPubMed
go back to reference Meininger CJ, Marinos RS, Hatakeyama K et al (2000) Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 349:353–356PubMedCentralCrossRefPubMed Meininger CJ, Marinos RS, Hatakeyama K et al (2000) Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 349:353–356PubMedCentralCrossRefPubMed
go back to reference Meininger CJ, Cai S, Parker JL et al (2004) GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. FASEB J 18:1900–1902PubMed Meininger CJ, Cai S, Parker JL et al (2004) GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. FASEB J 18:1900–1902PubMed
go back to reference Nystrom T, Nygren A, Sjoholm A (2004) Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease. Am J Physiol Endocrinol Metab 287:E919–E925CrossRefPubMed Nystrom T, Nygren A, Sjoholm A (2004) Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease. Am J Physiol Endocrinol Metab 287:E919–E925CrossRefPubMed
go back to reference Oppliger T, Thöny B, Nar H et al (1995) Structural and functional consequences of mutations in 6-pyruvoyltetrahydropterin synthase causing hyperphenylalaninemia in humans. Phosphorylation is a requirement for in vivo activity. J Biol Chem 270:29498–29506CrossRefPubMed Oppliger T, Thöny B, Nar H et al (1995) Structural and functional consequences of mutations in 6-pyruvoyltetrahydropterin synthase causing hyperphenylalaninemia in humans. Phosphorylation is a requirement for in vivo activity. J Biol Chem 270:29498–29506CrossRefPubMed
go back to reference Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR (2003) Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140:701–706PubMedCentralCrossRefPubMed Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR (2003) Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140:701–706PubMedCentralCrossRefPubMed
go back to reference Park HJ, Kang YM, Kim CH, Jung MH (2010) ATF3 negatively regulates adiponectin receptor 1 expression. Biochem Biophys Res Commun 400:72–77CrossRefPubMed Park HJ, Kang YM, Kim CH, Jung MH (2010) ATF3 negatively regulates adiponectin receptor 1 expression. Biochem Biophys Res Commun 400:72–77CrossRefPubMed
go back to reference Rader DJ (2007) Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12–S18CrossRefPubMed Rader DJ (2007) Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12–S18CrossRefPubMed
go back to reference Sheng L, Zhou Y, Chen Z et al (2012) NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med 18:943–949PubMedCentralCrossRefPubMed Sheng L, Zhou Y, Chen Z et al (2012) NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med 18:943–949PubMedCentralCrossRefPubMed
go back to reference Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G (2004) Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys 41:415–434CrossRefPubMed Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G (2004) Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys 41:415–434CrossRefPubMed
go back to reference Simaite D, Kofent J, Gong M et al (2014) Recessive mutations in PCBD1 cause a new type of early-onset diabetes. Diabetes 63:3557–3564CrossRefPubMed Simaite D, Kofent J, Gong M et al (2014) Recessive mutations in PCBD1 cause a new type of early-onset diabetes. Diabetes 63:3557–3564CrossRefPubMed
go back to reference Sumi-Ichinose C, Urano F, Kuroda R et al (2001) Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem 276:41150–41160CrossRefPubMed Sumi-Ichinose C, Urano F, Kuroda R et al (2001) Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem 276:41150–41160CrossRefPubMed
go back to reference Tai SC, Robb GB, Marsden PA (2004) Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol 24:405–412CrossRefPubMed Tai SC, Robb GB, Marsden PA (2004) Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol 24:405–412CrossRefPubMed
go back to reference Thöny B, Leimbacher W, Blau N, Harvie A, Heizmann CW (1994) Hyperphenylalaninemia due to defects in tetrahydrobiopterin metabolism: molecular characterization of mutations in 6-pyruvoyl-tetrahydropterin synthase. Am J Hum Genet 54:782–792PubMedCentralPubMed Thöny B, Leimbacher W, Blau N, Harvie A, Heizmann CW (1994) Hyperphenylalaninemia due to defects in tetrahydrobiopterin metabolism: molecular characterization of mutations in 6-pyruvoyl-tetrahydropterin synthase. Am J Hum Genet 54:782–792PubMedCentralPubMed
go back to reference Thöny B, Ding Z, Martinez A (2004) Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia. FEBS Lett 577:507–511CrossRefPubMed Thöny B, Ding Z, Martinez A (2004) Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia. FEBS Lett 577:507–511CrossRefPubMed
go back to reference Turri MO, Ilg EC, Thöny B, Blau N (1998) Structure, genomic localization and recombinant expression of the mouse 6-pyruvoyl-tetrahydropterin synthase gene. Biol Chem 379:1441–1447PubMed Turri MO, Ilg EC, Thöny B, Blau N (1998) Structure, genomic localization and recombinant expression of the mouse 6-pyruvoyl-tetrahydropterin synthase gene. Biol Chem 379:1441–1447PubMed
go back to reference VerHague MA, Cheng D, Weinberg RB, Shelness GS (2013) Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol 33:2501–2508CrossRefPubMed VerHague MA, Cheng D, Weinberg RB, Shelness GS (2013) Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol 33:2501–2508CrossRefPubMed
go back to reference Wang X, Hattori Y, Satoh H et al (2007) Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats. Eur J Pharmacol 555:48–53CrossRefPubMed Wang X, Hattori Y, Satoh H et al (2007) Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats. Eur J Pharmacol 555:48–53CrossRefPubMed
go back to reference Wang XA, Deng S, Jiang D et al (2013b) CARD3 deficiency exacerbates diet-induced obesity, hepatosteatosis, and insulin resistance in male mice. Endocrinology 154:685–697CrossRefPubMed Wang XA, Deng S, Jiang D et al (2013b) CARD3 deficiency exacerbates diet-induced obesity, hepatosteatosis, and insulin resistance in male mice. Endocrinology 154:685–697CrossRefPubMed
go back to reference Werner ER, Blau N, Thony B (2011) Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 438:397–414CrossRefPubMed Werner ER, Blau N, Thony B (2011) Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 438:397–414CrossRefPubMed
go back to reference Wu G, Meininger CJ (2002) Regulation of nitric oxide synthesis by dietary factors. Annu Rev Nutr 22:61–86CrossRefPubMed Wu G, Meininger CJ (2002) Regulation of nitric oxide synthesis by dietary factors. Annu Rev Nutr 22:61–86CrossRefPubMed
go back to reference Wyss CA, Koepfli P, Namdar M et al (2005) Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging 32:84–91CrossRefPubMed Wyss CA, Koepfli P, Namdar M et al (2005) Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging 32:84–91CrossRefPubMed
go back to reference Yan JQ, Tan CZ, Wu JH et al (2013) Neopterin negatively regulates expression of ABCA1 and ABCG1 by the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells. Mol Cell Biochem 379:123–131CrossRefPubMed Yan JQ, Tan CZ, Wu JH et al (2013) Neopterin negatively regulates expression of ABCA1 and ABCG1 by the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells. Mol Cell Biochem 379:123–131CrossRefPubMed
go back to reference Yang P, Wang Z, Zhan Y et al (2013) Endogenous A1 adenosine receptor protects mice from acute ethanol-induced hepatotoxicity. Toxicology 309:100–106CrossRefPubMed Yang P, Wang Z, Zhan Y et al (2013) Endogenous A1 adenosine receptor protects mice from acute ethanol-induced hepatotoxicity. Toxicology 309:100–106CrossRefPubMed
Metadata
Title
Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice
Authors
Germaine Korner
Tanja Scherer
Dea Adamsen
Alexander Rebuffat
Mark Crabtree
Anahita Rassi
Rossana Scavelli
Daigo Homma
Birgit Ledermann
Daniel Konrad
Hiroshi Ichinose
Christian Wolfrum
Marion Horsch
Birgit Rathkolb
Martin Klingenspor
Johannes Beckers
Eckhard Wolf
Valérie Gailus-Durner
Helmut Fuchs
Martin Hrabě de Angelis
Nenad Blau
Jan Rozman
Beat Thöny
Publication date
01-03-2016
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2016
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9909-6

Other articles of this Issue 2/2016

Journal of Inherited Metabolic Disease 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine